Jakarta, August 27th, 2021, PT. Mustika Ratu, Tbk (MRAT) has held the Annual General Meeting of Shareholders (“AGM”), the General Meeting of Shareholders (“EGM”), and Public Expose located in The Westin, Jakarta. The company submits the financial performance ended on December 31, 2020, as well as the exposure of the Company’s strategy in the fiscal year 2021.
Map business in the industry of healthcare, especially since the pandemic hit Indonesia at this time provide a great challenge as well as make an opportunity for the Company to grow more rapidly. The company realizes that the pattern of consumer behavior has shifted, especially since the presence of this pandemic. Pandemic COVID-19 has become the catalyst for consumers to switching consumer behavior from offline to online.
Read Also: Herbal Supplement for a Healthier Body
With the proceeding of the campaign stay at home by the Government then the whole activity of consumers at home ranging from shopping, entertainment, attending school from home and others. From space into the screen. Stay At Home Lifestyle. When the economic activities of many conventional that stopped because of the pandemic, then the activities of the digital economy to replace it so that the continuity of the economy is still running. Not surprising that digital transformation is key for the company to survive in the midst of a pandemic. Digital Transformation Is a Key.
President Commissioner Ir. Djoko Ramiadji, MSc said that “the Board of Commissioners supports the full performance of the board of Directors in strategic decision-making of the Company during the year 2020, so the Company is able to record a better performance.” The company has performed a variety of strategic efforts to maintain its market amid the siege of a pandemic, one of them by dividing the division sales and marketing into 2 Beauty and HealthCare. This is done in an effort to maximize the company’s sales.
Products HealthCare will continue to grow
The board of Commissioners to assess and monitor the performance of the board of directors during the year 2020 according to the functions and duties of the Commissioner. During the year 2020, the board of Directors has the reform the effective and efficient management and the impact on the performance of the Company. The company managed to deliver net sales in 2020 Rp.318,4 billion, an increase of Rp. 13.2 billion or 4% when compared with the year 2019 amounted to Rp.305,2 billion. The success of the board of Directors increases the net sales influenced by the success of the Company running the transformation of 4.0 and the foresight of the Company saw the opportunity to diversify the products with the launch of the latest product innovations, i.e. Hand Sanitizer and health supplements Herbamuno+ (HealthCare Division), so the decline in turnover in the other segments can be replaced by an increase in turnover in the line of HealthCare.
“The innovations made by the Company since the year 2020 with the how to do product diversification with the launch of the latest product innovations that Hand Sanitizer and health supplements Herbamuno+ (Health care division). The increase in net sales was caused by the success of the Company running the transformation of 4.0. And proven by the presence of new products above are able to increase the net sales of the Company’s significant, “ said President Director of PT Mustika Ratu Tbk (MRAT) Ir. Bingar Egidius Situmorang.
Until the first semester of 2021, the Company recorded net sales of Rp. 176,3 Billion ( one Hundred Seventy-Six Billion Three Hundred Million Rupiah) or 23.2% compared to the first semester of 2020 amounted to Rp 143,1 billion ( one Hundred Forty-Three Billion one Hundred Million Rupiah ). The increase in sales is contributed by the segment of the Beauty of 51.5% and a segment of Health Care by 276,7%.
Operationally, the Company earned a net profit in the first semester of 2021 Rp. 2.3 billion increased by Rp.803,8 million or increased by 55.3% compared to the first semester of 2020 amounted to Rp. 1.5 billion.
MRAT And Expanding the Distribution Network
One of the Company’s strategies is to develop the sales of the health products (Health Care) and in cooperation with PT Indofarma Global Medika that is one of the subsidiaries of PT. Indofarma Tbk (INAF) at the medical channel and expand the range of distribution through cooperation with PT. Sinarmas Distribusi Nusantara (SDN) has 330.000 point distribution in Indonesia.
The company is also expanding through channel telemedicine platform to strengthen and improve the awareness of consumers about the products of the Company, particularly in the digital platform by cooperating with various Key Opinion Leader (KOL).
The company plans to target a wider market and strengthen the product line that has been there. By targeting the millennial, product penetration Jejamu also will be more optimized moreover the momentum of the current health and herbs grow significantly in the middle of a pandemic. From the side of export, the Company will also continue to focus on the countries that have contributed significantly to sales.
With products Herbamuno+ which is currently in the process of clinical trials to be the product of phytopharmaca, the Company is confident that the business prospects in the segment of healthcare will continue to grow this year,” as presented by the Finance Director of PT Mustika Ratu Tbk (MRAT), Jodi Andrea Suryokusumo.
MRAT and Transformation
Although in market conditions and economic challenges, the Company is still able to position itself as the market leader in the industry of beauty and health for a local brand. The increase in sales reflects management “agile” and being able to adjust to market conditions. PT Mustika Ratu Tbk (MRAT) has established the Board of Commissioners and the Board of Directors of the results of General Meeting of Shareholders Outside the Usual (“EGM”) are derived from a variety of industries, including the fast-moving consumer goods industry (FMCG). In the ranks of the Board of Commissioners, has been established Ir. Djoko Ramiadji, MSc President Commissioner, Haryo Tejo Baskoro, MBA and Prof.DR.FG Winarno as Commissioner. To the Board of Directors; President Director of Ir. Bingar Egidius Situmorang, Director Jodi Andrea Suryokusumo, Bcom, MCorpGov, CA (ICAA), the Director of the Kusuma Ida Anjani BCom, MBus, MAppFin.
President Director Ir. Bingar Egidius Situmorang explained,” The transformation and the focus of the Company in the year 2021 include the development of the business in the category Holistic Beauty, Health & Wellness to all channel outlets tools and continue to maximize the potential of export to more countries. The company pursues a strategy as part of business development in the future, including Product Portfolio Refocusing, the Development of Network Marketing, Optimization Digital Marketing / Online, the Optimization of the Assets of the Company, and Increase the Quality of the Company’s Operations.”
The company is optimistic that it can improve the growth of its business and continue to develop the Company’s products not only in the domestic market but also in the international market.